Stanford University
Showing 24,251-24,300 of 34,422 Results
-
Thomas A. Rabedeau
Distinguished Staff Engineer 6, Stanford Synchrotron Radiation Lightsource
Current Role at StanfordSSRL special projects engineer
-
Benjamin Micah Raber
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Benjamin Raber is a board-certified, fellowship-trained surgical oncologist at Stanford Health Care. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Raber specializes in surgical treatments for benign and cancerous breast diseases. He performs a wide range of procedures, including lumpectomy, nipple-sparing mastectomy, and preventive mastectomy. Dr. Raber uses the latest and most effective surgical approaches, including wire-free, breast-conserving surgery for lumpectomies and hidden scar surgery (to hide incisions). He is committed to compassionate, patient-centered care that involves close collaboration with his colleagues in medical and radiation oncology, radiology, and plastic surgery.
Dr. Raber is actively involved in community outreach and breast cancer education. He has led regional initiatives to promote awareness, expand access to breast cancer screenings, and improve early detection.
Dr. Raber’s research focuses on improving surgical treatments for breast cancer, including better ways to treat cancer that has spread to nearby lymph nodes. He has also explored using ultrasound imaging to help surgeons locate and remove cancerous tissue more precisely during breast-conserving surgery. His research has been published in prominent peer-reviewed journals, including Annals of Surgical Oncology, Magnetic Resonance Imaging Clinics of North America, and The American Journal of Surgery.
Dr. Raber is a fellow of the American College of Surgeons (ACS) and a member of the American Society of Breast Surgeons (ASBrS). -
Marlene Rabinovitch
Dwight and Vera Dunlevie Professor of Pediatric Cardiology
Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.
-
Ralph Rabkin
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsDr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.
-
Cara Rada
Postdoctoral Scholar, Hematology
Current Research and Scholarly InterestsI develop human brain models to study neurological infection, cancer metastasis, and neurodegeneration. My research focuses on the brain’s blood vessels and brain resident immune cell, microglia, and investigates how alterations in these components of the brain microenvironment can have deleterious effects.
-
Lisa Radloff
Alternate Format & Assistive Technology Manager, Office of Accessible Education
Current Role at StanfordAlternate Format & Assistive Technology Manager, Office of Accessible Education
I manage a team of world class alternate format and Braille specialists who help disabled Stanford students get equitable access to course materials over their educational journeys.
Our team oversees the production of accessible educational materials and manage assistive technology for students with disabilities. -
Ramin Radmanesh, MD
Graduate, Stanford Center for Professional Development
BioPhysician, researcher, and lifelong learner exploring where medicine meets data and AI.
-
Helge Raeder MD PhD
Affiliate, Genetics
BioHelge Ræder is a Full Professor at the Faculty of Medicine, University of Bergen (UiB), Norway and a Senior Consultant in Pediatric Endocrinology at Haukeland University Hospital, Bergen, Norway. With a background in cellular biology and diabetes research, he has significantly contributed to understanding diabetes through stem cell research. He has been a visiting scholar at Joslin Diabetes Center, Harvard Medical School with C. Ronald Kahn (2005-2006) and with Rohit N Kulkarni (2010-2011). As the Vice Dean of Innovation at UiB (2017-2024), he has spearheaded the establishment of ecosystems that catalyze breakthrough innovations, including a new Medical Innovation Centre. His research aims to unravel the biology of diabetes and endocrine disorders, focusing on the interplay between genetics, proteomics, and stem cell biology. Dr. Ræder's work has resulted in publications in high-impact journals including Nature, Nature Genetics, Nature Metabolism, Diabetes, Journal of Bone and Mineral Research and Nature Reviews Endocrinology. He has been recognized with several awards, including the Young Investigator’s Award from the International Society for Pediatric and Adolescent Diabetes. He has been an invited speaker at the IPITA-JDRF-HSCI Key opinion leader´s meeting on stem cell-derived beta cells at Harvard Medical School. Currently, he is a visiting professor at Stanford University, contributing to precision health research focusing on developing endocrine digital twins at Prof. Michael Snyder's Lab.
-
Jillian Rafferty
CSA & Lecturer in Law, Internatl Human Rights & Conflict Resolution Clinic, Law Clinics
Current Research and Scholarly InterestsRafferty’s work has focused on the human rights of marginalized groups, discrimination, armed conflict and other humanitarian emergencies, counter-terrorism, and humanitarian disarmament. Her academic research interests include the co-application of international human rights law and international humanitarian law, the protection of economic, social, and cultural rights during armed conflict, and both gender- and disability-based violence and discrimination.
-
Thomas Raffin
The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus
Current Research and Scholarly InterestsDr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.
-
Nilima Ragavan
Clinical Professor, Pediatrics - Neonatology
BioDr Nilima Ragavan is a Neonatologist and Clinical Professor at the Stanford University School of Medicine. She is an experienced clinician who has expertise in the care of critically ill newborns.She is the Neonatal Outreach Medical director for Stanford Children's health, Co director of the Mid Coastal California Perinatal Outreach Program, and the Medical director of the Special care Nursery at Stanford Children's Health.She serves as a mentor to junior faculty. Dr Ragavan is passionate about education, and social justice. She has worked in and promoted social organizations in the fields of education, health care, livelihood and women's empowerment in India.She founded a group called Teach to Heal to promote cross cultural education and has led several multidisciplinary medical teams to India, as well as organized and conducted international neonatal and perinatal conferences.
-
Krishna Raghavan
Ph.D. Student in Chemistry, admitted Autumn 2024
BioKrishna is originally from the Detroit area of Michigan, and completed his undergraduate studies in biological chemistry and chemistry at the University of Chicago. He is currently a second-year PhD student concentrating in biophysical chemistry, in the lab of Prof. Bianxiao Cui.
-
Srinivas Raghu
Professor of Physics
BioI am interested in the emergent behavior of quantum condensed matter systems. Some recent research topics include non-Fermi liquids, quantum criticality, statistical mechanics of strongly interacting and disordered quantum systems, physics of the half-filled Landau level, quantum Hall to insulator transitions, superconductor-metal-insulator transitions, and the phenomenology of quantum materials.
Past contributions that I'm particularly proud of include the co-founding of the subject of topological photonics (with Duncan Haldane), scaling theories of non-Fermi liquid metals (with Shamit Kachru and Gonzalo Torroba), Euclidean lattice descriptions of Chern-Simons matter theories and their dualities in 2+1 dimensions (with Jing-Yuan Chen and Jun Ho Son), and 'dual' perspectives of quantum Hall transitions (with Prashant Kumar and Michael Mulligan). -
Amer Raheemullah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Amer Raheemullah, MD, is Associate Clinical Professor of Psychiatry and Behavioral Sciences at Stanford University. He is the Director of Stanford Hospital Addiction Services (shas.stanford.edu), which he initially launched at a single site, and after demonstrating significant improvements in patient outcomes, led its expansion across Stanford’s multiple hospital sites.
His research and insights on habits and addictive behavior have been published in leading journals including JAMA and Cambridge University Press, and has been featured in media outlets such as Bloomberg News, ABC7 News, KQED, and Everyday Health. He has been invited to advise on national addiction policy by the U.S. Food and Drug Administration (FDA), the U.S. Department of Health and Human Services (HHS), the Substance Abuse and Mental Health Services Administration (SAMHSA), as well as the Congress-established Reagan-Udall Foundation. He has also consulted for several Silicon Valley digital health startups focused on habits and addictive behaviors, such as Lucid Lane, where he led the development and expansion of clinical programs that enabled the organization to grow from a single-state initiative into a nationally operating program within a few years.
His academic work focuses on translating research into scalable models of addiction treatment that can be integrated into health care systems, digital health interventions, and public policy to expand access to high-quality, evidence-based care. Since completing his addiction medicine training at Stanford University School of Medicine, he has continued to work directly with patients across a wide range of settings, including community-based programs, sober living environments, outpatient clinics, residential treatment facilities, inpatient units, and correctional settings.
